CAS 82626-01-5
:Alpidem
- 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide
- 6-Chlor-2-(4-chlorphenyl)-N,N-dipropylimidazol(1,2-a)pyridin-3-acetamid
- 6-Chloro-2-(4-chlorophenyl)-N,N-dipropylimidazo[1,2-a]pyridine-3-acetamide
- 6-Chloro-2-(p-chlorophenyl)-N,N-dipropylimidazo(1,2-a)pyridine-3-acetamide
- Alpidem [USAN:INN:BAN]
- Alpidemum
- Alpidemum [Latin]
- Ananxyl
- Imidazo(1,2-a)pyridine-3-acetamide, 6-chloro-2-(4-chlorophenyl)-N,N-dipropyl-
- Sl 80.0342-00
- Unii-I93Sc245Qz
- Weitere Synonyme anzeigen
Alpidem
CAS:Kontrolliertes ProduktApplications A peripheral benzodiazepine GABAA receptor ligand, a new anxiolytic.
References Min, D., et al.: Pharmacotherapy, 12, 68 (1992), Rothwell, C., et al.: J. Toxicol. Sci., 27, 35 (2002), Gonzalez-Diaz, H., et al.: Bioorg. Med. Chem. Lett., 15, 1651 (2005), Boelsterli, U., et al.: Curr. Drug Metab., 7, 715 (2006), Rietjens, I., et al.: Chem. Res. Toxicol., 19, 977 (2006),Formel:C21H23Cl2N3OFarbe und Form:NeatMolekulargewicht:404.33Alpidem
CAS:Kontrolliertes ProduktAlpidem is a low-potency short-acting benzodiazepine that is used as a sedative or hypnotic. It is also used for the treatment of insomnia, anxiety disorders, and panic disorder. Alpidem has significant interactions with other drugs such as triazolam, lorazepam and clozapine. It binds to the α1 subunit of the GABAA receptor and increases the activity of gamma-aminobutyric acid (GABA) in the brain by increasing its synthesis and inhibiting its degradation. Alpidem also has been shown to have some anxiolytic effects in animal models.
Formel:C21H23Cl2N3OReinheit:Min. 95%Farbe und Form:White To Tan SolidMolekulargewicht:404.33 g/molAlpidem
CAS:Alpidem (Ananxyl), a non-sedative imidazopyridine anxiolytic, treats anxiety with high benzodiazepine receptor affinity.Formel:C21H23Cl2N3OReinheit:99.56% - 99.97%Farbe und Form:White To Off-White SolidMolekulargewicht:404.33Ref: TM-T26600
1mg62,00€5mg144,00€10mg219,00€25mg393,00€50mg550,00€100mg787,00€500mg1.596,00€1mL*10mM (DMSO)129,00€




